The acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.
Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due to a thrombus or embolus, resulting in brain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.
Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labeling are trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.
However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.
Segment Review
The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.
Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.
Region wise, North America is poised to be the highest revenue generator by 2023.
Competition Analysis
The major players operating in the global acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Acute ischemic stroke (AIS) is a fatal condition that includes abrupt obstruction of blood flow to the brain, leading to neurological dysfunction. The blockage is typically caused due to a thrombus or embolus, resulting in brain tissue ischemia and infarction. Sudden weakness, difficulty speaking or understanding speech, numbness on one side of the body, vision problems, severe headaches, and dizziness are the most common symptoms of AIS. Immediate diagnosis for the condition involves clinical assessment and neuroimaging via CT or MRI, which is pivotal to timely restore the blood flow and reduce brain damage.
Increase in the prevalence of AIS, particularly in the elderly population, is boosting the demand for acute ischemic stroke diagnosis. The elderly population is growing exponentially across the globe and dynamic changes in lifestyle are leading to rise in the occurrence of life-threatening conditions among them. Moreover, surge in expenditure on healthcare and diagnostic technologies is a key driver of the market. Non-invasive imaging techniques such as arterial spin labeling are trending for the diagnosis of AIS in recent times. Such techniques enable measurement of cerebral blood flow non-invasively, hence helping to assess the tissue viability with quick & precise diagnosis.
However, the expense associated with such cutting-edge diagnosis techniques is significantly high which prevents the low-income population from leveraging its benefits, hence hampering the market development. Moreover, the reimbursement landscape for acute ischemic stroke diagnosis is highly inconsistent and challenging, thereby restricting the growth of the market. On the contrary, the consistent efforts by government to reduce the prevalence of AIS is anticipated to present lucrative opportunities for the market. For instance, the European Stroke Organization began an initiative called Stroke Action Plan for Europe in 2018 which aims to improve the preventive action for stroke until 2030.
Segment Review
The acute ischemic stroke diagnosis market is segmented into technology, end user, and region. On the basis of technology, the market is divided into computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. Depending on end user, it is classified into hospitals & clinics, ambulatory surgery centers, diagnostic laboratories and imaging centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of technology, the computed tomography segment acquired high stakes at the market in 2023.
Depending on end user, the hospitals & clinics segment was the highest shareholder in 2023.
Region wise, North America is poised to be the highest revenue generator by 2023.
Competition Analysis
The major players operating in the global acute ischemic stroke diagnosis market include Koninklijke Philips N.V., GE Healthcare, Canon Inc., Simens, Terumo Corporation, Stryker, Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, F. Hoffmann-La Roche Ltd, and Boehringer Ingelheim International GmbH. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Technology
- Computed Tomography
- Magnetic Resonance Imaging
- Carotid Ultrasound
- Cerebral Angiography
- Electrocardiography
- Echocardiography
- Others
By End User
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Diagnostic Laboratories and Imaging Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Koninklijke Philips N.V.
- GE Healthcare
- Canon Inc.
- Simens
- Terumo Corporation
- Stryker
- Fujifilm Holdings Corporation
- Samsung Electronics Co. Ltd
- F. Hoffmann-La Roche Ltd
- Boehringer Ingelheim International GmbH
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY
CHAPTER 5: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER
CHAPTER 6: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
Key Market Players in the Acute Ischemic Stroke Diagnosis Market include:- Koninklijke Philips N.V.
- GE Healthcare
- Canon Inc.
- Simens
- Terumo Corporation
- Stryker
- Fujifilm Holdings Corporation
- Samsung Electronics Co. Ltd
- F. Hoffmann-La Roche Ltd
- Boehringer Ingelheim International GmbH
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 228 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 2.1 billion |
| Forecasted Market Value ( USD | $ 3.6 billion |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
